View
For US Consumers
     
Understanding Onglyza
TEXT
A
A
A

Even though you do your best to manage your type 2 diabetes, it can be tough to keep your blood sugar under control. One option your doctor has is adding once-daily Onglyza (saxagliptin). Ask your doctor if Onglyza is right for you.

Onglyza is a once-daily prescription medicine for adults with type 2 diabetes that enhances the body's natural ability to control blood sugar. Onglyza, along with diet and exercise, may help reduce after-meal blood sugar spikes. Onglyza also may help lower the blood sugar between meals. Onglyza should not be used to treat people with type 1 diabetes or to treat diabetic ketoacidosis (increased ketones in the blood
or urine).

Onglyza may help lower A1C, morning blood sugar (FPG), and after-meal blood sugar (PPG) when added to one of several common oral diabetes medicines, such as metformin, a thiazolidinedione (TZD), or a sulfonylurea. Individual results may vary.

Most people taking Onglyza did not experience hypoglycemia (very low blood sugar); however, it may occur, particularly when taken with another diabetes medicine, such as a sulfonylurea or insulin. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor's instructions for treating low blood sugar.

Serious side effects can happen to people taking Onglyza, including inflammation of the pancreas (pancreatitis), which may be severe and lead to death. Before taking Onglyza, tell your doctor if you have ever had pancreatitis. Stop taking Onglyza and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

Here's how Onglyza may give you extra help to treat high blood sugar:

  • Onglyza may reduce after-meal blood sugar spikes and may help lower blood sugar between meals.
  • Onglyza may help significantly lower your A1C. A1C is the test done by your doctor every 3 months. Ask your doctor for your A1C score. It's an important step in managing your type 2 diabetes.
  • Onglyza is a once-daily pill that works for 24 hours.
  • Onglyza can be taken with or without food.
  • In clinical trials, Onglyza did not affect most people's weight.
Next: See How Onglyza Works to help
lower your blood sugar.
The Value Card Program for Onglyza
Easy and instant savings for eligible patients.

Talk to Your Doctor
Need help talking with your doctor about type 2 diabetes? The Doctor Discussion Guide can help.
Get Started

IMPORTANT SAFETY INFORMATION
for ONGLYZA (saxagliptin)

Do not take ONGLYZA (saxagliptin) if you are allergic to any of its ingredients. Serious allergic reactions can occur with ONGLYZA and may include swelling of the face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives, rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA and contact your doctor right away.

Serious side effects can happen to people taking ONGLYZA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking ONGLYZA, tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism, or high triglyceride levels. Stop taking ONGLYZA and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

WHAT IS ONGLYZA?

ONGLYZA (saxagliptin) is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

ONGLYZA should not be used to treat people with type 1 diabetes or diabetic ketoacidosis (increased ketones in the blood or urine).

If you have had inflammation of the pancreas (pancreatitis), it is not known if you have a higher chance of getting pancreatitis while taking ONGLYZA.

When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

Your doctor should test your blood to measure how well your kidneys are working before and during treatment with ONGLYZA. You may need a lower dose if your kidneys are not working well.

Tell your doctor if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your doctor may need to change your dose of ONGLYZA.

Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant or breast-feed.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please click here for Medication Guide, and click here for US Full Prescribing Information for ONGLYZA (saxagliptin).

This product information is intended for US customers only.
ONGLYZA® is a trademark of Bristol-Myers Squibb Company. ©2012 Bristol-Myers Squibb Company.
422US12WA05401 04/12 1761201

US Full Prescribing Information   Medication Guide  Unsubscribe  Privacy Statement  Legal Notice   Site Map

BMS Logo AstraZeneca Logo

Bristol-Myers Squibb Patient Assistance Foundation:
This non-profit organization provides assistance to
qualifying patients with financial hardship who generally
have no prescription insurance. Contact 1-800-736-0003
or visit www.bmspaf.org for more information.